Meetings & Education

Teratogen Updates

Teratogen Update Presentations


Teratology Research in the Shadow of the Dobbs Decision

63rd Annual Meeting, June 27, 2023


Developmental Origins of Health and Disease in the ECHO Program

62nd Annual Meeting, June 28, 2022


Identifying New Human Teratogens: Revisiting Shepard's Criteria

Virtual 61st Annual Meeting, June 24, 2021


From Dysmorphology to Next-Generation Phenotyping

Virtual 60th Annual Meeting, June 25, 2020


Congenital Heart Defects Research: Finding the Hidden Crossroads Between Genetics and Environment

59th Annual Meeting, June 25, 2019
San Diego, California


Progress against Malaria, the Role of Antimalarial Drugs, and Their Use in Pregnancy

58th Annual Meeting, June 26, 2018
Clearwater, Florida


In Bed with the Devil: Recognizing Human Teratogenic Exposures

57th Annual Meeting, June 27, 2017
Denver, Colorado


Preventing the Preventable: Where Do We Stand on Fetal Alcohol Spectrum Disorders in 2016?

56th Annual Meeting, June 28, 2016
San Antonio, TX


Genetic Mutations Cause Many Birth Defects: What We Learned from the FORGE Canada Project

55th Annual Meeting, June 30, 2015
Montréal, Québec, Canada


Teratology and Public Health: Working Together to Make Recommendations for Pregnant Women in the Face of Uncertainty

54th Annual Meeting, July 2, 2014
Bellevue, Washington


Definitive Noninvasive Prenatal Diagnosis Using Maternal Blood

53rd Annual Meeting, June 24, 2013
Tucson, Arizona


Does Assisted Reproductive Technology (ART) Increase the Risk of Birth Defects?

52nd Annual Meeting, June 26, 2012
Baltimore, Maryland


Update on Human Teratogens

51st Annual Meeting, June 26, 2011
Coronado, California


Human Teratogens: Update 2010

50th Annual Meeting, June 28, 2010
Louisville, Kentucky


Human Teratogens: The Year in Review

49th Annual Meeting, June 28, 2009
Puerto Rico


Human Teratogens: The Year in Review

48th Annual Meeting, June 30, 2008
Monterey, California

Teratogen Update Publications

Informative articles on important subjects published in Birth Defects Research arranged by year. All articles are Adobe Acrobat files.


Antithyroid Drugs - Methimazole, Carbimazole, and Propylthiouracil

Orna Diav-Citrin and
Asher Ornoy

Azathioprine and

Janine E. Polifka and
J. M. Friedman


Lyme Disease Daniel J. Elliott, Stephen C. Eppes, and Joel D. Klein
John M. DeSesso
Mildred S. Christian and
obert L. Brent

Reproductive Risks of Leflunomide (Arava™); A Pyrimidine Synthesis Inhibitor: Counseling Women Taking Leflunomide Before or During Pregnancy and Men Taking Leflunomide Who Are Contemplating Fathering a Child

Robert L. Brent


Maternal myasthenia gravis as a cause of congenital arthrogryposis

A. Polizzi, S.M. Huson, and
A. Vincent


Thalidomide: a review, with a focus on ocular findings and new potential uses

Marilyn T. Miller and
Kerstin Strõmland

Paternal exposures - reproductive risks

Jacquetta M. Trasler and Tonia Doerksen

Radiation and chernobyl

Frank P. Castronovo Jr.

Methylene blue

Janet D. Cragan


Gestational effects of maternal hyperthermia due to febrile illnesses and resultant patterns of defects in humans

John M. Graham Jr.,
Matthew J. Edwards, and
Marshall J. Edwards

Congenital rubella

William S. Webster


Fetal effects of indomethacin administration during pregnancy

Mary E. Norton

Smoking and reproductive outcomes

Martha M. Werler

Iodine deficiency, a community teratogen

Joseph G. Hollowell Jr. and
W. Harry Hannon

Polychlorinated biphenyls

Joseph L. Jacobson, and Sandra W. Jacobson


Louise Wilkins-Haug

PDF files require Adobe Acrobat reader software